每年專案
個人檔案
學歷
- 2001.08-2005.08 Ph.D. Department of Food Science and Biotechnology, National Chung Hsing University
- 2006.01-2010.01 Post-Doctoral Fellow, National Institute of Cancer Research (National Health Research Institutes)
經歷
- 2010.04- Assistant Professor, Graduate Institute of Clinical Medicine, Taipei Medical University
- 2014.02- Research Fellow and Executive Secretary, Taipei Medical University-Shuang Ho Hospital
獎項
- Chi-Tai Yeh received his Ph.D. in Food Science and Biotechnology from National Chung Hsing University. Dr. Yeh is currently the Research Fellow and Executive Secretary of Department of Research of Taipei Medical University-Shuang Ho Hospital. Dr. Yeh has contributed 2 book chapters, published 46 articles in the field of cancer & nutritional chemistry journal, and got 2 patents in the medical compound of cancer therapy. His major research interests include in cancer cell biology, cancer stem cell research, nutrigenomis and cancer chemoprevention with dietary phytochemicals.
研究興趣
- Cancer cell biology
- Cancer stem cell research
- Nutrigenomis and cancer chemoprevention with dietary phytochemicals
指紋
查看啟用 Chi-Tai Yeh 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
- 1 類似的個人檔案
網路
國家/地區層面的近期外部共同作業。按一下圓點深入探索詳細資料，或
專案
- 2 已完成
-
4-Acetylantroquinonol B induced DNA damage response signaling and apoptosis via suppressing CDK2/CDK4 expression in triple negative breast cancer cells
Satriyo, P. B., Su, C. M., Ong, J. R., Huang, W. C., Fong, I. H., Lin, C. C., Aryandono, T., Haryana, S. M., Deng, L., Huang, C. C., Tzeng, Y. M., Chao, T. Y., Liu, H. W. & Yeh, C. T., 七月 1 2021, 於: Toxicology and Applied Pharmacology. 422, 115493.研究成果: 雜誌貢獻 › 文章 › 同行評審
1 引文 斯高帕斯（Scopus） -
Combined treatment with acalabrutinib and rapamycin inhibits glioma stem cells and promotes vascular normalization by downregulating btk/mtor/vegf signaling
Su, Y. K., Bamodu, O. A., Su, I. C., Pikatan, N. W., Fong, I. H., Lee, W. H., Yeh, C. T., Chiu, H. Y. & Lin, C. M., 九月 2021, 於: Pharmaceuticals. 14, 9, 876.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Garcinol attenuates lipoprotein(A)-induced oxidative stress and inflammatory cytokine production in ventricular cardiomyocyte through α7-nicotinic acetylcholine receptor-mediated inhibition of the p38 mapk and nf-κb signaling pathways
Chang, N. C., Yeh, C. T., Lin, Y. K., Kuo, K. T., Fong, I. H., Kounis, N. G., Hu, P. & Hung, M. Y., 三月 2021, 於: Antioxidants. 10, 3, p. 1-19 19 p., 461.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Genome-wide CRISPR/Cas9 knockout screening uncovers a novel inflammatory pathway critical for resistance to arginine-deprivation therapy
Chu, C. Y., Lee, Y. C., Hsieh, C. H., Yeh, C. T., Chao, T. Y., Chen, P. H., Lin, I. H., Hsieh, T. H., Shih, J. W., Cheng, C. H., Chang, C. C., Lin, P. S., Huang, Y. L., Chen, T. M., Yen, Y., Ann, D. K. & Kung, H. J., 2021, 於: Theranostics. 11, 8, p. 3624-3641 18 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取1 引文 斯高帕斯（Scopus） -
High-grade b-cell lymphoma (Hgbl) with myc and bcl2 and/or bcl6 rearrangements is predominantly bcl6-rearranged and bcl6-expressing in Taiwan
Tsai, C. C., Su, Y. C., Bamodu, O. A., Chen, B. J., Tsai, W. C., Cheng, W. H., Lee, C. H., Hsieh, S. M., Liu, M. L., Fang, C. L., Lin, H. T., Chen, C. L., Yeh, C. T., Lee, W. H., Ho, C. L., Lai, S. W., Tzeng, H. E., Hsieh, Y. Y., Chang, C. L., Zheng, Y. M. 及其他4, , 四月 1 2021, 於: Cancers. 13, 7, 1620.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取
資料集
-
Cisplatin resistant lung cancer cells promoted M2 polarization of tumor-associated macrophages via the Src/CD155/MIF functional pathway
Huang, W. (Contributor), Kuo, K. (Contributor), Wang, C. (Contributor), Yeh, C. (Contributor) & Wang, Y. (Contributor), Unknown Publisher, 一月 1 2019
DOI: 10.6084/m9.figshare.c.4488140.v1, https://doi.org/10.6084%2Fm9.figshare.c.4488140.v1
資料集: Dataset
-
Additional file 2: of Cisplatin resistant lung cancer cells promoted M2 polarization of tumor-associated macrophages via the Src/CD155/MIF functional pathway
Huang, W. (Contributor), Kuo, K. (Contributor), Wang, C. (Contributor), Yeh, C. (Contributor) & Wang, Y. (Contributor), Unknown Publisher, 一月 1 2019
DOI: 10.6084/m9.figshare.8057534.v1, https://springernature.figshare.com/articles/Additional_file_2_of_Cisplatin_resistant_lung_cancer_cells_promoted_M2_polarization_of_tumor-associated_macrophages_via_the_Src_CD155_MIF_functional_pathway/8057534/1
資料集: Dataset
-
Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor
Kuo, K. (Contributor), Huang, W. (Contributor), Bamodu, O. A. (Contributor), Lee, W. (Contributor), Wang, C. (Contributor), Hsiao, M. (Contributor), Wang, L. (Contributor) & Yeh, C. (Contributor), Unknown Publisher, 八月 9 2018
DOI: 10.6084/m9.figshare.c.4194263.v1, https://figshare.com/collections/Histone_demethylase_JARID1B_KDM5B_promotes_aggressiveness_of_non-small_cell_lung_cancer_and_serves_as_a_good_prognostic_predictor/4194263/1
資料集: Dataset
-
Additional file 1: of Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor
Kuo, K. (Contributor), Huang, W. (Contributor), Bamodu, O. A. (Contributor), Lee, W. (Contributor), Wang, C. (Contributor), Hsiao, M. (Contributor), Wang, L. (Contributor) & Yeh, C. (Contributor), Unknown Publisher, 八月 9 2018
DOI: 10.6084/m9.figshare.6953516.v1, https://springernature.figshare.com/articles/Additional_file_1_of_Histone_demethylase_JARID1B_KDM5B_promotes_aggressiveness_of_non-small_cell_lung_cancer_and_serves_as_a_good_prognostic_predictor/6953516/1
資料集: Dataset
-
Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448
Bamodu, O. A. (Contributor), Huang, W. (Contributor), Lee, W. (Contributor), Wu, T. A. (Contributor), Wang, L. (Contributor), Hsiao, M. (Contributor), Yeh, C. (Contributor) & Chao, T. (Contributor), Unknown Publisher, 二月 25 2016
DOI: 10.6084/m9.figshare.c.3621719.v1, https://figshare.com/collections/Aberrant_KDM5B_expression_promotes_aggressive_breast_cancer_through_MALAT1_overexpression_and_downregulation_of_hsa-miR-448/3621719/1
資料集: Dataset